- Home
- AIRT vs VNRX Comparison
AIRT vs VNRX Comparison
Compare AIRT & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRT
- VNRX
- Stock Information
- Founded
- AIRT 1980
- VNRX N/A
- Country
- AIRT United States
- VNRX United States
- Employees
- AIRT N/A
- VNRX N/A
- Industry
- AIRT Air Freight/Delivery Services
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AIRT Consumer Discretionary
- VNRX Health Care
- Exchange
- AIRT Nasdaq
- VNRX Nasdaq
- Market Cap
- AIRT 59.0M
- VNRX 52.4M
- IPO Year
- AIRT N/A
- VNRX N/A
- Fundamental
- Price
- AIRT $22.70
- VNRX $0.75
- Analyst Decision
- AIRT
- VNRX Strong Buy
- Analyst Count
- AIRT 0
- VNRX 5
- Target Price
- AIRT N/A
- VNRX $3.88
- AVG Volume (30 Days)
- AIRT 4.1K
- VNRX 156.5K
- Earning Date
- AIRT 08-13-2025
- VNRX 08-13-2025
- Dividend Yield
- AIRT N/A
- VNRX N/A
- EPS Growth
- AIRT N/A
- VNRX N/A
- EPS
- AIRT N/A
- VNRX N/A
- Revenue
- AIRT $291,850,000.00
- VNRX $1,308,361.00
- Revenue This Year
- AIRT N/A
- VNRX $563.72
- Revenue Next Year
- AIRT N/A
- VNRX $160.43
- P/E Ratio
- AIRT N/A
- VNRX N/A
- Revenue Growth
- AIRT 1.75
- VNRX 64.16
- 52 Week Low
- AIRT $14.56
- VNRX $0.40
- 52 Week High
- AIRT $26.70
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- AIRT 54.67
- VNRX 55.55
- Support Level
- AIRT $21.87
- VNRX $0.71
- Resistance Level
- AIRT $26.70
- VNRX $0.79
- Average True Range (ATR)
- AIRT 1.02
- VNRX 0.06
- MACD
- AIRT 0.04
- VNRX -0.00
- Stochastic Oscillator
- AIRT 30.56
- VNRX 71.43
About AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.